Analyst Research

Report Title Price
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Genetic Technologies Ltd Announces Temporary Corporate Restructure


Monday, 14 Oct 2013 07:02pm EDT 

Genetic Technologies Ltd announced that Chief Executive Officer, Ms. Alison Mew, will be stepping aside from her day-to-day responsibilities for a period of three months, as from October 15, 2013. She is taking this step for personal, health-related reasons. During the period of her absence, Mr. Tom Howitt will assume the role of Acting CEO alongside his current duties as the Company's CFO. 

Company Quote

0.038
 --
25 May 2015